Canada committed a grave error and left medical cannabis patients behind with legalization. The U.S. can avoid this mistake.
President Donald Trump’s Dec. 18 executive order, aimed at modernizing U.S. policy on medical marijuana and CBD, expanded research opportunities – and created enough optimism to trigger a flurry of cannabis M&A.
But one fundamental question remains unanswered. How will medical cannabis actually be delivered to patients?
Canada faced this same question nearly a decade ago – and got it badly wrong.
How Canada fumbled medical cannabis with nationwide legalization
In 2016, Canada expanded nationwide access to medical cannabis. At the time, I was working at Shoppers Drug Mart, Canada’s largest pharmacy retailer, where I focused on new healthcare ventures.
I am a licensed pharmacist by training, and like many healthcare professionals, I was initially skeptical of cannabis as medicine.
That changed after meeting patients and hearing their stories firsthand. I later went on to launch and lead a national medical cannabis distribution platform under the Shoppers banner.
Read the full article at MJBizDaily
